Glenview baby formula maker close to $16.6B sale

SHARE Glenview baby formula maker close to $16.6B sale

Glenview-based Mead Johnson has been acquired by Reckitt Benckiser. | File photo

The U.K.’s Reckitt Benckiser, which makes products ranging from condoms to Lysol, says it’s in advanced talks to buy the U.S. baby formula company Mead Johnson.

Reckitt said it plans to offer $90 for each Mead Johnson share, or about $16.6 billion. That’s a 30 percent premium from Mead Johnson’s Wednesday closing stock price, a day before word of the deal began to be discussed publicly.

Mead Johnson, based in Glenview, Illinois, makes Enfamil infant formula and other nutritional drinks for infants and children. Reckitt Benckiser Group Plc. is based in London. Its other brands include Nurofen pain medicine and Air Wick air fresheners.

Shares of Mead Johnson Nutrition Co. gained 21 percent to close at $84.38 Thursday.

The Latest
The couple’s organization supports around 20 youth music programs around Chicago. On Sunday, the students will hold a concert.
The will of past Democratic leadership seemed to be to not overtly poke any big, cash-rich bears, like the National Rifle Association. That might be changing.
Officials said the pregnancy could bring up to five new cubs to the zoo, an “exciting” prospect for both the zoo and a “vulnerable” African lion population.
Only two free agent shortstops remain out of this winter’s Big 4.